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To the Editor: In some tropical 
areas, melioidosis, a disease caused by 
infection with Burkholderia pseudom-
allei, results in sepsis (1). This disease 
affects mostly adults with an underly-
ing predisposing condition (2). With 
the increase in international travel, 
melioidosis has been identifi ed in pa-
tients returning from disease-endemic 
areas (3). We report a case of a trav-
el-associated cutaneous melioidosis 
without any systemic involvement.
A 90-year-old woman came to 
the Hôpital Erasme in Brussels with a 
nonhealing erythematous and ulcerat-
ed cutaneous lesion on the side of her 
left elbow. The lesion was a  papule 
that gradually increased in size. The 
patient had diabetes mellitus but was 
otherwise healthy when she had trav-
eled to Bangladesh 8 weeks earlier. 
She stayed 3 weeks in a village in the 
northwestern area of Rangpur District 
during the rainy season. She reported 
multiple insect and mosquito bites that 
evolved into intensely pruritic papules. 
This led to uncontrolled scratching 
and repeated washing of bite lesions 
with untreated well water. 
Two weeks after her return, the 
lesion developed; it increased steadily 
in size, despite application of topical 
antimicrobial ointment. Three weeks 
later, after three visits to a physician, 
she was admitted to our institution. 
She did not report any fever, rigors, 
sweating, malaise, weight loss, or re-
spiratory symptoms. Skin examination 
showed an irregular (3.0 cm × 4.0 cm), 
erythematous, fl uctuant, tender, pain-
ful plaque (online/Appendix Figure, 
panel A, available from www.cdc.gov/
EID/content/13/6/946-appG.htm). 
She did not have palpable regional 
lymph nodes. Results of a physical 
examination and laboratory investiga-
tions were normal. Five blood cultures 
at different times failed to isolate any 
microorganism. 
A skin biopsy specimen from the 
plaque showed an infl ammatory gran-
ulomatous reaction. Gram staining 
of biopsy specimens showed scanty 
lymphocytes, no polymorphonuclear 
leukocytes, and no microorganisms. 
Specimens were ground and placed 
on Columbia agar containing 5% 
horse blood and Schaedler enrichment 
broth and incubated aerobically for 3 
days and on Schaedler agar contain-
ing 5% horse blood and incubated 
anaerobically for 10 days. After 72 
hours, Schaedler broth showed a few 
colonies of an aerobic gram-nega-
tive bacillus that was identifi ed as B. 
pseudomallei on the basis of typical 
biochemical characteristics. The strain 
was mobile at 37°C; grew at 42°C, 
oxidized but did not ferment glucose; 
produced cytochrome oxidase, argi-
nine dihydrolase, and gelatinase; and 
was resistant to 300 IU polymyxin B 
300 (DiaTabs; Rosco, Taastrup, Den-
mark). The isolate had a negative reac-
tion for metabolism of arabinose. 
Antimicrobial drug testing showed 
susceptibility to temocillin, amoxi-
cillin-clavulanic acid (MIC 2 mg/L), 
piperacillin-tazobactam, ceftazidime, 
cefepime, meropenem (MIC 0.75 mg/
L), doxycycline, and cotrimoxazole, 
and resistance to cefazolin, cefoxitin, 
ampicillin, gentamicin, ciprofl oxacine, 
and amikacin. Results of tests for sys-
temic involvement, as well as sputum 
and urine cultures, were negative. The 
patient was discharged and received 
oral doxycycline, 100 mg twice a day, 
and amoxicillin/clavulanic acid, 875 
mg twice a day, for 32 weeks. The le-
sion dramatically improved 8 weeks 
after treatment was started (Appendix 
Figure, panel B) and had disappeared 
by 20 weeks after treatment was start-
ed (Appendix Figure, panel C). At 24 
months after the diagnosis, no relapse 
had occurred.
Our patient with imported melioi-
dosis had an unusual clinical course. 
She had never been febrile and had an 
uncomplicated localized skin infection 
skin despite her predisposing diabetes. 
A similar course has been reported in 2 
tourists from Finland after the tsunami 
in Thailand in December 2004 (4), but 
most imported cases have pulmonary 
or systemic involvement associated 
with a severe prognosis (5,6).
The mode of acquisition in our 
patient herein was probably by an in-
sect bite, contaminated water, or direct 
contact with wet soil during the rainy 
season. This mode of acquisition rein-
forces the hypothesis of a predominant 
role of percutaneous B. pseudomal-
lei infection (7). Although the lesion 
healed, the patient was advised to have 
lifelong follow-up because relapses 
have been observed several years after 
infection.
Imported melioidosis is no lon-
ger a rare disease. With the increase 
in international travel and adventure 
tourism to disease-endemic regions, 
melioidosis is more likely to develop 
among travelers, even in those with 
short-term exposure. Recent reports 
suggest that melioidosis is probably 
widespread but poorly recognized 
throughout Bangladesh (5). Clinicians 
who treat patients returning from dis-
ease-endemic tropical areas, includ-
ing the Indian subcontinent, should 
consider the disease in the differential 
diagnosis of febrile illnesses and iso-
lated skin ulcers. Diagnosis is based 
on isolation of B. pseudomallei from 
blood, sputum, or biopsy specimens 
from lesions. Microbiologists should 
also be aware of the characteristics of 
the agent, and cultures should be han-
dled under laboratory biosafety level 3 
containment. Moreover, B. pseudom-
allei is a potential bioterrorism agent 
(8). Assessment of geographic and 
seasonal exposure is needed for identi-
fi ying this polymorphic exotic disease. 
Furthermore, travel advertisements to 
disease-endemic countries should in-
clude prophylactic measures to avoid 
contact with wet soils and contami-
nated water.
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Coronaviruses in 
Children, Greece
To the Editor: Two recently de-
tected human coronaviruses (HCoVs), 
NL63 and HKU1, increased the num-
ber of coronaviruses known to infect 
humans to 5 (1–3). HCoV-229E and 
HCoV-NL63 belong to antigenic 
group 1, HCoV-OC43 and HCoV-
HKU1 belong to antigenic group 2, 
and severe acute respiratory syndrome 
(SARS)–associated coronavirus 
(SARS-CoV) is most closely related 
to group 2 coronaviruses. In 2005, 
an optimized pancoronavirus reverse 
transcription–PCR assay was used to 
explore the incidence of HCoV-NL63 
infection in children in Belgium who 
had a diagnosis of respiratory tract in-
fection (4). We report the results of an 
epidemiologic study that used a uni-
versal coronavirus RT-PCR assay to 
detect coronaviruses among children 
in Greece with acute respiratory tract 
infections.
We tested throat swab specimens 
obtained from children hospitalized 
in Greece during June 2003 through 
May 2004 (200 children 2 months to 
14 years of age, mean 4.09 years) and 
during December 2005 through March 
2006 (44 children 1.6–8.5 years of 
age, mean 5.05). Specimens were 
obtained the fi rst day of each child’s 
hospitalization, and all specimens 
were included in the study, regardless 
whether other respiratory microorgan-
isms were detected.
The 25-μL reaction contained 
200 μM dNTPs, 0.2 μM primer 
PC2S2 (equimolar mixture of 5′-
TTATGGGTTGGGATTATC-3′ and 
5′-TGATGGGATGGGACTATC-3′), 
0.8 μM primer PC2As1 (5′-TCAT-
CAGAAAGAATCATCA-3′), 1 μL of 
enzyme mix from the QIAGEN One-
Step RT-PCR Kit (QIAGEN GmbH, 
Hilden, Germany), and 5 μL of RNA. 
The initial 30-min reverse transcrip-
tion step at 48°C was followed by 
10 cycles of 20 sec at 94°C, 30 sec at 
62°C with a decrease of 1°C per cycle, 
40 sec at 72°C; 40 cycles of 20 sec at 
94°C, 30 sec at 52°C, 40 sec at 72°C; 
and a fi nal extension step at 72°C for 
10 min. To determine the sensitivity 
after optimization, we tested quanti-
fi ed RNA in vitro transcripts that in-
cluded the natural primer binding sites 
of the respective coronavirus genomes. 
Sensitivities for SARS-CoV, HCoV-
OC43, HCoV-229E, and HCoV-NL63 
were 61.0, 800.0, 8.2, and 82.3 nomi-
nal RNA copies per assay, respec-
tively. A separate test was not done for 
HCoV-HKU1 because it had the same 
primer binding sites as HCoV-OC43. 
A phylogenetic tree based on a 400-bp 
genome fragment of the polymerase 
gene was constructed (online Appen-
dix Figure, available from www.cdc.
gov/EID/13/6/947-appG.htm).
Of 200 samples collected in 
2003–2004, 5 (2.5%) were positive for 
coronaviruses (2 each for HCoV-NL63 
and HCoV-229E and 1 for HCoV-
OC43), and of 44 samples collected 
in 2005–2006, 2 (4.5%) were positive 
for coronaviruses (1 for HCoV-229E 
and 1 for HCoV-OC43) (GenBank ac-
cession nos. EF103180–EF103184, 
EF394298, and EF394299). CoV-
HKU1 was not detected.
The amplifi ed genome region is 
one of the most conserved regions of 
the coronavirus genome. However, 
sequences for HCoV-NL63 strains 
isolated in Greece are genetically 
closer to the sequence for a strain 
(AY567487) isolated in Amsterdam in 
2003 (1) than to a strain (AY518894) 
from a specimen collected in Rot-
terdam in 1988 (2) (0.6% vs. 1.1% 
nucleotide divergence). Sequences for 
HCoV-229E and HCoV-OC43 strains 
isolated in Greece differ from se-
quences for strains isolated elsewhere 
by 0.5%–1.7%.
The HCoV-NL63–positive speci-
mens in our study were obtained from 
a 9- and a 14-month-old child during 
winter 2003–2004; no cases were iden-
tifi ed during 2005–2006. Specimens 
positive for HCoV-229E and HCoV-
OC43 were detected during both study 
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